A significant trend in anti-cancer drug development is the search for therapeutic compounds that are not substrates of drug efflux transporters.
← all excerpts
Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
1
—
—